AIM
SCLN

Alambic Investment Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Alambic Investment Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-24,300
Closed -$267K – 645
2017
Q2 		$267K Sell
24,300
-10,600
-30% -$116K 0.03% 476
2017
Q1 		$342K Buy
34,900
+21,900
+168% +$215K 0.04% 480
2016
Q4 		$140K Buy
+13,000
New +$140K 0.02% 526